Skip to content

News

Neobiomics AB and Gennisium Pharma announce an exclusive collaboration for distribution of ProPrems® in France

Stockholm October 12, 2021 – Neobiomics and Gennisium Pharma have entered into a Distribution Agreement under which Gennisium has the exclusive rights to register, market and sell Neobiomics’ proprietary product ProPrems® in France, in effect immediately. ProPrems® is a high-quality product for safe food supplementation… Read More »Neobiomics AB and Gennisium Pharma announce an exclusive collaboration for distribution of ProPrems® in France

Global business development as key competence

With extensive knowledge from the pharmaceutical industry and having participated in successful launches of innovative products, Mårten Österlund is now Chairman for Neobiomics’ Board of Directors. In this interview, Mårten shares his extraordinary story. He was part of a dedicated team that led MEDAs expansion to become a multi-national company and now he is an advisor for start-ups. What can be learnt and why did he connect… Read More »Global business development as key competence